Pancreatic cancer (PC) is a highly aggressive disease with unmet therapeutic needs. Recent advances in the use of oncolytic viruses (OVs) as cancer therapeutic agents bring new hope to fight the notorious disease that is PC. Although OVs have shown promising results in certain cancers, some tumors remain resistant to OV therapy due to their inherent residual antiviral mechanisms. We hypothesized that the use of OV-encoded artificial microRNAs (amiRNAs) could help target the cellular antiviral components associated with the observed OV resistance and could also sensitize neighboring tumor cells to OV therapy and small molecule inhibitors through the secretion of amiRNA-containing extracellular vesicles (EVs) from infected cells. To find such amiRNAs, a viral surrogate library encoding ~16,000 unique amiRNAs was passaged in pancreatic cancer cell lines to enrich for sequences that could enhance OV replication. An amiRNA that improves PC cell killing when expressed from an OV was identified. Target identification of this amiRNA (amiR-4) revealed ARID1A as a key player in resistance to OV therapy in pancreatic cancers. This target is of particular interest, since its downregulation acts in a synthetic lethal fashion with inhibition of the EZH2 methyltransferase. Combining VSV51-amiR-4 with a small molecule inhibitor of EZH2 enhances PC cell death. Moreover, amiR-4 is packaged in cancer cell-secreted EVs which can reach neighboring naïve cells to sensitize them to EZH2 inhibition-mediated cell death and to spread the OV-mediated tumor killing effect throughout the tumor. This data translates into tumor debulking and survival in animal models of highly aggressive PC. This work not only broadens our knowledge on the resistance of select tumors to oncolytic virotherapy and the EV-mediated bystander killing effect in OV-infected tumors, but it also establishes OVs as a novel tool to produce anti-cancer therapeutic EVs in situ to improve therapeutic gain. Ultimately, our work provides new hope for a cure to the grim disease that is PC.

The collective nature of group affiliation may inhibit an individual from exhibiting prosocial behavior regarding acts of religiously-motivated terror. This study's purpose was to investigate the nature of bystander intervention as it relates to religious group affiliation. Darley and Latane's bystander effect theory provided the theoretical framework for this study. The research questions examined the impact of religious group affiliation and group size on the dependent variables of civic moral disengagement (CMD) and commitment to the war on terror (CWT). Three validated survey instruments were administered to a random participant pool of 206 respondents. An ANCOVA and Spearman's rho correlation were employed to address the research questions. Findings revealed that neither religious group affiliation nor group size significantly predicts either CWT or CMD after controlling for the degree of religious commitment. Further research should test alternative theories associated with leadership and group dynamics. Positive social change is advanced by acknowledging that bystanders to acts of terrorism may not be influenced by factors such as group affiliation or size of religious group affiliations. These findings underscore the complexity of the relationship between behavior and religious affiliation. Policy makers and future researchers may benefit by redirecting their focus for prevention and intervention toward influences such as the motivational dynamic between religious leaders and their followers.

The effects of low doses of ionizing radiation on living things is a continually evolving area of research. Importantly, low dose effects were historically overlooked and not properly accounted for the assessment of risk to human health, as is the case with the contentious linear no-threshold model. These low dose effects are now known to be relevant to human health in both accidental and intentional exposures, including doses relevant to medical diagnostics and therapeutics. Furthermore, there is a relative dearth of information on low dose effects in non-human species, which necessitates further investigation and evaluation of radiosensitivity. Radiation-induced bystander effects occur in organisms due to the receipt of signals from directly irradiated cells, which act to communicate radiation damage to surrounding cells. Recent research has identified one type of bystander signal which is carried by photons of biological origin, however the effects produced in bystander cells receiving these photons has not been extensively investigated. It was suspected, based on previous research, that reactive oxygen species participate in the manifestation of this bystander effect. Three mammalian cell lines were assessed for their ability to produce bystander photons upon direct irradiation; subsequently, radiologically unexposed cells were exposed to the resulting photons and assayed for biological effects. The human cell lines used exhibited significant photon emissions and oxidative stress, clonogenic cell death, reduced cellular metabolism, and compromised mitochondrial oxidative phosphorylation following exposure to these photons. The use of a melanocyte cell line indicated that these effects are attenuated by melanin, and this is suspected to occur through photoabsorption or antioxidant mechanisms. Additionally, the same assays were conducted following cell exposure to hydrogen peroxide at low concentrations to assess responses to oxidative stress relevant to bystander responses, indicating less overall sensitivity in the examined melanocytes. These findings are significant because they contribute to our understanding of the mechanisms behind low dose biological effects, because they further challenge the linear no-threshold model and other models based on target theory, because they provide evidence for differential responses to the physical bystander signal in non-human species, and because secondary photon emissions are likely relevant to the medical radiation sciences. / Thesis / Master of Science (MSc) / Low doses of ionizing radiation interact with living things differently than high doses. Low dose effects are now known to be relevant to human health and protection of the environment. Radiation-induced bystander effects occur in cells due to the receipt of signals from irradiated cells which act to communicate radiation damage to surrounding cells. One type of bystander signal is carried by photons emitted from directly irradiated cells, however the effects produced in bystander cells receiving these photons has not been extensively investigated. This thesis investigates the cellular effects of these “biophotons”, including cell survival, oxidative stress, and metabolism.

Yes / (1) Abdominal aortic aneurysm (AAA) is a silent, progressive disease with significant mortality from rupture. Whilst screening programmes are now able to detect this pathology early in its development, no therapeutic intervention has yet been identified to halt or retard aortic expansion. The inability to obtain aortic tissue from humans at early stages has created a necessity for laboratory models, yet it is essential to create a timeline of events from EARLY to END stage AAA progression. (2) We used a previously validated ex vivo porcine bioreactor model pre-treated with protease enzyme to create "aneurysm" tissue. Mechanical properties, histological changes in the intact vessel wall, and phenotype/function of vascular smooth muscle cells (SMC) cultured from the same vessels were investigated. (3) The principal finding was significant hyperproliferation of SMC from EARLY stage vessels, but without obvious histological or SMC aberrancies. END stage tissue exhibited histological loss of α-smooth muscle actin and elastin; mechanical impairment; and, in SMC, multiple indications of senescence. (4) Aortic SMC may offer a therapeutic target for intervention, although detailed studies incorporating intervening time points between EARLY and END stage are required. Such investigations may reveal mechanisms of SMC dysfunction in AAA development and hence a therapeutic window during which SMC differentiation could be preserved or reinstated. / This research was funded in part by The Leeds Teaching Hospitals Charitable Foundation (R11/8002). E.R.C. was supported by a PhD studentship from the Engineering and Physical Sciences Research Council (EPSRC; EP/F500513/1). R.J.H. was the recipient of an Intercalated Batchelor of Science Degree in Science award from the Royal College of Surgeons of England. M.A.B.(FS/18/12/33270 and FS/12/54/29671), K.I.B. (FS/12/26/29395), and K.J.G. (FS/11/91/29090) were supported by BHF Clinical Research Training Fellowships.

O melanoma representa menos de 5% de todos os cânceres de pele, porém, quando em estádio metastático possui prognóstico ruim. Entretanto, o genótipo dos melanomas pode prover uma oportunidade para intervenção terapêutica pelo fato de 90% dos casos de melanoma possuem p53 selvagem e grande parte destes possuem deleção na região cromossômica codificadora de interferon beta. Em prévios estudos, desenvolvemos o vetor adenoviral AdRGD-PG que fornece expressão do transgene em resposta à p53 através do promotor PG e ainda o tripeptídeo RGD, que possibilita que o adenovírus transduza uma maior gama de células pela alteração de seu mecanismo de entrada. Temos utilizado este vetor para entrega da versão murina de interferon beta em modelos de terapia gênica e imunoterapia de melanoma murino, revelando uma significativa habilidade do interferon beta em inibir a proliferação celular in vitro e in vivo e promover resposta imune antitumoral. No presente trabalho, os esforços se aplicam em adaptar essa estratégia em modelo de melanoma humano para observar se a mesma interação é encontrada. O vetor AdRGD-PGhIbeta, portador do cDNA de interferon beta humano (hIbeta) foi construído e expressão do transgene observada após transdução das linhagens estabelecidas de melanoma humano SK-MEL-05 e SK-MEL-147 (ambas p53 selvagem). Foi observado um robusto efeito antitumoral in vitro onde transferência de hIbeta promoveu acumulo de células hipodiploides (mais que 80% da população celular 96 horas após transdução) e evidências de morte por apoptose (exposição de fosfatidilserina e atividade de caspases 3/7) em ambas as linhagens. Nas duas linhagens, o efeito bystander foi demonstrado quando a presença de poucas células transduzidas (ex., 10%) foi suficiente para promover o acumulo significativo de células hipodiploides (mais que 40% neste exemplo). Em modelo de terapia gênica in situ utilizando células SK-MEL-147, também foi observado forte efeito antitumoral da hIbeta com total remissão do tumor de todos os animais tratados sem recidiva durante noventa dias. A presença de hIbeta na circulação dos animais foi confirmada 48h após o tratamento com AdRGD-PG hbeta mas presente em somente dois de sete animais 90 dias após o tratamento, sugerindo que o tratamento inicial e não um efeito off target foi responsável pela resposta. Com a finalidade de investigar efeitos colaterais do sequestro do vetor adenoviral pelo fígado, observamos a concentração circulante das enzimas aminotransferase de aspartate e aminotransferase de alanine (AST e ALT, respectivamente), que se mostrou não alterada quando comparadas entre animais que receberam injeção do vetor tratamento, vetor controle e solução salina. Com nossos resultados concluímos que vetores adenovirais carreando interferon-beta humano são capazes de transduzir a linhagem de melanoma SK-MEL-147 in vitro e in vivo, promovendo efeito bystander e remissão tumoral sem indução de efeitos adversos / Melanoma represents less than 5% of all cases of skin cancer, although, when metastatic, prognosis is dire. However, the genotype of melanomas might provide an opportunity for therapeutic intervention since 90% of melanoma cases possess wild-type p53 and a great portion of these possess deletion of the chromosomal region encoding interferon beta. In previous studies, we developed the adenoviral vector AdRGD-PG that supplies expression of the transgene in response to p53 through the PG promoter and that utilizes the RGD tripeptide, allowing the adenovirus to transduce a wider range of cells due to the alterated mechanism of entrance. We have used this vector to deliver the murine version of interferon beta in murine models of melanoma gene therapy and immunotherapy, revealing a significant ability of interferon beta to inhibit cellular proliferation in vitro and in vivo and promote an anti-tumor immune response. In the present project, we aimed to adapt this strategy for a human melanoma model in order to reveal if the same impact will be observed. The AdRGD-PGhIbeta vector encoding the human interferon beta (hIbeta) cDNA was constructed and expression of the transgene confirmed after transduction of the established human melanoma cell lines SK-MEL-05 and SK-MEL-147 (both wild-type p53). A striking anti-tumor effect was observed in vitro where the transfer of hIbeta promoted an accumulation of hypodiploid cells (over 80% of the cellular population 96 hours after transduction) and evidence of death by apoptosis (exposure of phosphatidylserine and activity of caspases 3/7) in both cell lines. In these cell lines, a bystander effect was demonstrated when the presence of few transduced cells (ex., 10%) was enough to promote significant accumulation of hypodiploid cells (over 40% in this example). In a model of in situ gene therapy using SK-MEL-147 cells, hIbeta induced a strong anti-tumor effect including total tumor remission in all treated animals without relapse during ninety days. The presence of hIbeta in the circulation of the animals was confirmed 48h after treatment with AdRGD-PGhIbeta, but was present in only two of the seven animals 90 days post-treatment, suggesting that the initial treatment, not off target effects, was responsible for the response. With the goal of investigating collateral effects of adenoviral sequestration by the liver, we assayed the circulating concentration of aspartate aminotransferase and alanine aminotransferase (AST and ALT, respectively), which showed no alteration when compared with animals that received the treatment with a control vector or saline solution. We conclude that our adenoviral vector carrying human interferon-beta is capable of transducing the human melanoma cell line SK-MEL-147 in vitro and in vivo, promoting a bystander effect and tumor remission without inducing adverse effects

L'effet de voisinage radio-induit s'observe dans les cellules voisines de cellules irradiées mais non directement touchées par l'irradiation. A ce jour, les espèces réactives de l'oxygène (EROs) sont considérées comme ayant un rôle actif dans la survenue de réponse au voisinage, mais leur implication n'est pas encore totalement définie. Afin de déterminer leur impact dans la réponse au voisinage, à la fois temporellement et spatialement, des irradiations par microfaisceau de particules sont mises au point afin de cibler une fraction définie de cellules au niveau du noyau dans une culture cellulaire. Les irradiations sont pratiquées sur des cellules normales ostéoblastiques, à sous-confluence, nommées MC3T3-E1. L'observation directe de la génération d'EROs cellulaires et mitochondriales révèle que la réponse bystander est caractérisée par un stress cellulaire d'origine double et temporellement distinct. A court terme, la signalisation issue de la membrane induit une importante production d'EROs impliquée dans l'apparition de cassures double brin de l'ADN retardées. Les mitochondries produisant des EROs jusque 6 heures après l'irradiation semblent être impliquées dans un processus à long terme différent. L'étude indépendante de la réponse des cellules ciblées et voisines met en évidence un phénomène nouveau. L'effet de voisinage induit une réponse des cellules voisines mais est aussi impliqué dans une amplification de la réponse des cellules ciblées par l'irradiation. Ainsi toute cellule, irradiée ou non, peut recevoir ces signaux bystander et répondre. L'ensemble de cette étude mène à considérer les cultures cellulaires comme des réseaux complexes de communication; leurs réponses à l'irradiation indiquent une relation mêlée entre signaux relatifs à l'irradiation elle-même et réponse au voisinage. Cette complexité du phénomène d'effet de voisinage peut justifier que son incidence sur l'établissement de règles de radioprotection et sur la courbe linéaire sans seuil n'est pas encore clairement déterminée.

O melanoma representa menos de 5% de todos os cânceres de pele, porém, quando em estádio metastático possui prognóstico ruim. Entretanto, o genótipo dos melanomas pode prover uma oportunidade para intervenção terapêutica pelo fato de 90% dos casos de melanoma possuem p53 selvagem e grande parte destes possuem deleção na região cromossômica codificadora de interferon beta. Em prévios estudos, desenvolvemos o vetor adenoviral AdRGD-PG que fornece expressão do transgene em resposta à p53 através do promotor PG e ainda o tripeptídeo RGD, que possibilita que o adenovírus transduza uma maior gama de células pela alteração de seu mecanismo de entrada. Temos utilizado este vetor para entrega da versão murina de interferon beta em modelos de terapia gênica e imunoterapia de melanoma murino, revelando uma significativa habilidade do interferon beta em inibir a proliferação celular in vitro e in vivo e promover resposta imune antitumoral. No presente trabalho, os esforços se aplicam em adaptar essa estratégia em modelo de melanoma humano para observar se a mesma interação é encontrada. O vetor AdRGD-PGhIbeta, portador do cDNA de interferon beta humano (hIbeta) foi construído e expressão do transgene observada após transdução das linhagens estabelecidas de melanoma humano SK-MEL-05 e SK-MEL-147 (ambas p53 selvagem). Foi observado um robusto efeito antitumoral in vitro onde transferência de hIbeta promoveu acumulo de células hipodiploides (mais que 80% da população celular 96 horas após transdução) e evidências de morte por apoptose (exposição de fosfatidilserina e atividade de caspases 3/7) em ambas as linhagens. Nas duas linhagens, o efeito bystander foi demonstrado quando a presença de poucas células transduzidas (ex., 10%) foi suficiente para promover o acumulo significativo de células hipodiploides (mais que 40% neste exemplo). Em modelo de terapia gênica in situ utilizando células SK-MEL-147, também foi observado forte efeito antitumoral da hIbeta com total remissão do tumor de todos os animais tratados sem recidiva durante noventa dias. A presença de hIbeta na circulação dos animais foi confirmada 48h após o tratamento com AdRGD-PG hbeta mas presente em somente dois de sete animais 90 dias após o tratamento, sugerindo que o tratamento inicial e não um efeito off target foi responsável pela resposta. Com a finalidade de investigar efeitos colaterais do sequestro do vetor adenoviral pelo fígado, observamos a concentração circulante das enzimas aminotransferase de aspartate e aminotransferase de alanine (AST e ALT, respectivamente), que se mostrou não alterada quando comparadas entre animais que receberam injeção do vetor tratamento, vetor controle e solução salina. Com nossos resultados concluímos que vetores adenovirais carreando interferon-beta humano são capazes de transduzir a linhagem de melanoma SK-MEL-147 in vitro e in vivo, promovendo efeito bystander e remissão tumoral sem indução de efeitos adversos / Melanoma represents less than 5% of all cases of skin cancer, although, when metastatic, prognosis is dire. However, the genotype of melanomas might provide an opportunity for therapeutic intervention since 90% of melanoma cases possess wild-type p53 and a great portion of these possess deletion of the chromosomal region encoding interferon beta. In previous studies, we developed the adenoviral vector AdRGD-PG that supplies expression of the transgene in response to p53 through the PG promoter and that utilizes the RGD tripeptide, allowing the adenovirus to transduce a wider range of cells due to the alterated mechanism of entrance. We have used this vector to deliver the murine version of interferon beta in murine models of melanoma gene therapy and immunotherapy, revealing a significant ability of interferon beta to inhibit cellular proliferation in vitro and in vivo and promote an anti-tumor immune response. In the present project, we aimed to adapt this strategy for a human melanoma model in order to reveal if the same impact will be observed. The AdRGD-PGhIbeta vector encoding the human interferon beta (hIbeta) cDNA was constructed and expression of the transgene confirmed after transduction of the established human melanoma cell lines SK-MEL-05 and SK-MEL-147 (both wild-type p53). A striking anti-tumor effect was observed in vitro where the transfer of hIbeta promoted an accumulation of hypodiploid cells (over 80% of the cellular population 96 hours after transduction) and evidence of death by apoptosis (exposure of phosphatidylserine and activity of caspases 3/7) in both cell lines. In these cell lines, a bystander effect was demonstrated when the presence of few transduced cells (ex., 10%) was enough to promote significant accumulation of hypodiploid cells (over 40% in this example). In a model of in situ gene therapy using SK-MEL-147 cells, hIbeta induced a strong anti-tumor effect including total tumor remission in all treated animals without relapse during ninety days. The presence of hIbeta in the circulation of the animals was confirmed 48h after treatment with AdRGD-PGhIbeta, but was present in only two of the seven animals 90 days post-treatment, suggesting that the initial treatment, not off target effects, was responsible for the response. With the goal of investigating collateral effects of adenoviral sequestration by the liver, we assayed the circulating concentration of aspartate aminotransferase and alanine aminotransferase (AST and ALT, respectively), which showed no alteration when compared with animals that received the treatment with a control vector or saline solution. We conclude that our adenoviral vector carrying human interferon-beta is capable of transducing the human melanoma cell line SK-MEL-147 in vitro and in vivo, promoting a bystander effect and tumor remission without inducing adverse effects

Upon assuming the presidency of the Republic of Korea in 2013, Park Geun-hye announced her administration’s priority to address the country’s “Four Social Evils”—sexual violence, domestic violence, school bullying, and unsafe food products. As part of this initiative, the ROK national government urged police officers to implement anti-bullying campaigns and curb school violence. This study examined the effects of Stand By Me: Bullying Prevention and Bystander Empowerment, an anti-bullying presentation conducted by a ROK police officer for an audience of South Korean high school students in spring 2016. The study employed a nonequivalent groups design with a designated treatment group and comparison group, but was limited to a posttest survey only. The focus of the study was whether a police-administered bullying prevention presentation had an effect on Korean high school students’ attitudes toward bullying and their willingness to intervene to stop bullying, and was examined using independent-samples t tests and Mann-Whitney U tests. The relationship between moral approval of bullying and bystander intervention willingness was also examined, as well as the relationships between other key variables and bystander intervention willingness. These relationships were examined via regression analysis. The study yielded statistically significant findings indicating that students who were administered the Stand By Me presentation were less likely to support bullying and more likely to be willing to intervene in bullying incidents compared to students who did not participate in the presentation. Moral approval of bullying had only a minor impact on bystander intervention willingness, whereas perceived peer support, self-esteem, and informal social control had a greater influence on students’ inclination to intervene. Due to the limited scope of this project, it is recommended that future studies and evaluations conducted on Stand By Me and other anti-bullying programs in South Korea utilize more rigorous research designs that incorporate pretesting and random assignment. Nevertheless, given the paucity of empirical research on police anti-bullying initiatives in the ROK, one of the overarching goals of this study is to encourage further dialogue on preventing bullying, one of the endemic ‘social evils’ plaguing today’s youth, in South Korea and around the world, and the appropriate role of law enforcement in this arena.

<p>This thesis describes an analysis of the influence of dose and dose rate from low LET radiation on the induction of a cytotoxic bystander effect. The general direction was as follows:</p> <p>a) Utilize a well – established reporter cell line with two types of low – LET radiation across varying dose and dose rates in order to assess the possibility of a dose rate effect. These results identified the recovery of bystander cell survival to control levels after high dose treatment. Additionally, dose rate effects were seen at high dose treatments following electron irradiation as well as between similar low – LET sources.</p> <p>b) Apply aggressive radiation treatment for toxic medium production in order to elicit a bystander cell death response in a cell line with no previous observed effect. Results indicated a similar response to a reporter line including an increase in cell survival at high doses. Transforming growth factor β1 (TGF-β1) was identified as necessary to the observed effect.</p> <p>c) Develop a dosimetry model for <em>in vitro</em> bystander studies following toxic medium production with a β-emitting radiopharmaceutical. Furthermore, use this model to re-examine survival fraction data in comparison with traditional external beam treatment. A code-base and application were developed. Comparison between treatments indicated a similar survival curve shape with differences in the magnitude of the response. This is possibly the result of cell response to low – dose rates from radiopharmaceutical treatment.</p> <p>The overall conclusion points to the importance of dose rate in observed bystander cell death as well as the differentiating response at high doses. Additionally, the similarity in survival curve behaviour across differing cell type's further points to common underlying critical mechanisms. However, it is believed that further data acquisition and aggregation is required in order to build a robust model for the influence of these factors.</p> / Doctor of Philosophy (PhD)

Victims of domestic violence (DV) are growing, still the number of cases reported isn't. In Rättvik only half the amount of cases are reported compared to two years ago. Rättvik is working to reduce DV by starting the project "Våga Hjälpa!". The purpose of this study was to use a quantitative approach to examine if the project is known in Rättvik. The study's based on a survey with a 27% response rate. The analysis was made by SPSS and interpreted on the basis of conformity, the bystander effect and the Theory of Planned Behaviour. Results show that the majority haven't been in contact with DV and that the knowledge of how to act is evenly spread. The study concludes with an objective evalution of "Våga Hjälpa!" where our study results are related to the project objectives. The evaluation partly shows a fullfilled result but also some improvement opportunities. / Allt fler blir offer för våld i nära relationer, trots detta ökar inte anmälda relationsvåldsbrott. I Rättviks kommun ser man idag en halvering av anmälda våldsbrott i jämförelse med två år tillbaka. Kommunen arbetar aktivt för att minska relationsvåldsbrott och har startat projektet "Våga hjälpa!". Syftet med denna studie var att med en kvantitativ ansats undersöka i vilken utsträckning projektet "Våga Hjälpa!" är känt bland Rättviks invånare. Studien bygger på en enkätundersökning med en svarsfrekvens på 27%. Analysen av materialet har gjorts genom SPSS för att sedan tolkas utifrån konformitet, åskådareffekten samt Theory of Planned Behaviour. Resultatet av studien visar att majoriteten av respondenterna inte kommit i kontakt med relationsvåld samt en jämn spridning avseende kunskap om hur man ska agera. Studien avslutas med en målutvärdering av "Våga Hjälpa!" där resultatet av vår studie relateras till projektets mål. Denna utvärdering påvisar delvis ett uppfyllt resultat men även vissa förbättringsmöjligheter.